Lect2 Controls Inflammatory Monocytes to Constrain the Growth and Progression of Hepatocellular Carcinoma

Hepatology - United States
doi 10.1002/hep.30140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Inhibition of VEGF165/VEGFR2-dependent Signaling by LECT2 Suppresses Hepatocellular Carcinoma Angiogenesis

Scientific Reports
Multidisciplinary
2016English

Long Non‑coding RNA Igf2as Controls Hepatocellular Carcinoma Progression Through the ERK/MAPK Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Ferroportin in the Progression and Prognosis of Hepatocellular Carcinoma

European Journal of Medical Research
Medicine
2013English

HSP90 Interacts With HMGCR and Promotes the Progression of Hepatocellular Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

HBx Regulates Transcription Factor PAX8 Stabilization to Promote the Progression of Hepatocellular Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Neutrophils: Driving Progression and Poor Prognosis in Hepatocellular Carcinoma?

British Journal of Cancer
Cancer ResearchOncology
2017English

FAT10 Overexpression Disturbs WISP1 Protein and mRNA Expression to Promote Hepatocellular Carcinoma Progression

Hepatology
MedicineHepatology
2018English

Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development

ISRN Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy